Learn more

SHANGHAI CELL THERAPY RES INST

Overview
  • Total Patents
    68
  • GoodIP Patent Rank
    21,387
  • Filing trend
    ⇩ 6.0%
About

SHANGHAI CELL THERAPY RES INST has a total of 68 patent applications. It decreased the IP activity by 6.0%. Its first patent ever was published in 2015. It filed its patents most often in China, WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are FINNISH NAT PUBLIC HEALTH, LI HUASHUN and GRACELL BIOTECHNOLOGIES SHANGHAI CO LTD.

Patent filings in countries

World map showing SHANGHAI CELL THERAPY RES INSTs patent filings in countries

Patent filings per year

Chart showing SHANGHAI CELL THERAPY RES INSTs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Jin Huajun 68
#2 Qian Qijun 68
#3 Li Linfang 61
#4 Wang Chao 45
#5 Jiang Duqing 31
#6 He Zhou 30
#7 Cui Lianzhen 22
#8 Liu Xiangzhen 21
#9 Wu Hongping 14
#10 Sun Juanjuan 13

Latest patents

Publication Filing date Title
CN110028588A Antigen-Fc fusion protein and its application for detecting positive CAR-T cell
CN109988759A A kind of chimeric promoters in T cell with high transcriptional activity
CN109971719A Autocrine CD40 antibody and the CAR-T cell and application thereof for targeting ErbB receptor family
CN109971725A Chimeric antigen receptor modification T cell of antibody modification and application thereof
CN109971718A The method for obtaining high positive rate CAR-T cell
CN109971837A A kind of detection method and kit of exogenous antibodies gene copy number
CN109970864A A kind of two-way activation costimulatory molecules receptor and application thereof
CN109971716A EGFR specific C AR-T cell of autocrine CD47 antibody and application thereof
CN109971723A T cell and application thereof comprising CD40 antibody Yu muc1 specific chimeric antigen receptor gene
CN109971717A Co-express the T cell and application thereof of CD40 antibody and mesothelin specific chimeric antigen receptor
CN109971721A From the mesothelin specific C AR-T cell and application thereof of expression CD47 antibody
CN109971720A Target the Chimeric antigen receptor modification T cell and application thereof of ErbB receptor family
CN109971713A Stablize the Muc1 specific C AR-T cell and application thereof of expression PD-1 antibody
CN109971836A The method and kit of double fluorescent quantitative PCR measurement CAR copy number
CN109971835A A kind of probe that lock nucleic acid is modified and a kind of method for measuring CAR copy number
CN109971724A It targets ErbB receptor family and expresses the CAR-T cell and application thereof of PD-1 antibody certainly
CN109970867A A kind of two-way activation costimulatory molecules receptor of CD40 and application thereof
CN109970865A A kind of two-way activation costimulatory molecules receptor of CD137 and application thereof
CN109971712A Selectively targeted CD19 antigen and high level stablize the CAR-T cell and purposes of expression PD-1 antibody
CN109971722A It targets CD19 and high level stablizes the CAR-T cell and application thereof of expression CD40 antibody